ストックスクリーナーアプリを入手
0.71
2.74%
-0.02
アフターアワーズ：
.72
0.01
+1.41%
前日終値:
$0.73
開ける：
$0.7081
24時間の取引高:
119.08K
Relative Volume:
0.54
時価総額：
$63.69M
収益：
-
当期純損益:
$-30.15M
株価収益率:
-0.7802
EPS:
-0.91
ネットキャッシュフロー:
$-31.63M
1週間 パフォーマンス:
-15.58%
1か月 パフォーマンス:
+13.15%
6か月 パフォーマンス:
-22.26%
1年 パフォーマンス:
-68.16%
1日の値動き範囲:
$0.70
$0.7667
1週間の範囲:
$0.70
$0.875
52週間の値動き範囲:
$0.49
$2.75
Context Therapeutics Inc Stock (CNTX) Company Profile
名前
Context Therapeutics Inc
セクター
電話
267-225-7416
住所
2001 MARKET STREET, PHILADELPHIA
CNTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNTX
Context Therapeutics Inc
|
0.71 | 65.48M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-21 | 開始されました | William Blair | Outperform |
| 2025-01-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-11-25 | 開始されました | D. Boral Capital | Buy |
| 2024-05-16 | 開始されました | Piper Sandler | Overweight |
Context Therapeutics Inc (CNTX) 最新ニュース
What makes Context Therapeutics Inc. stock price move sharplyShort Term Opportunity Finder with Tools - Newser
Detecting support and resistance levels for Context Therapeutics Inc.Bollinger Band Squeeze and Expansion Analysis - Newser
What technical models suggest about Context Therapeutics Inc.’s comebackAsset Safety Selection Using Quantitative Analysis - Newser
How Context Therapeutics Inc. stock performs during market volatilityTop Stock Picks with Forecast Accuracy - Newser
Custom strategy builders for tracking Context Therapeutics Inc.Entry Optimization Guide with Volume Analysis - Newser
How sentiment analysis helps forecast Context Therapeutics Inc.Technical Analysis of Growth Stock Opportunities - Newser
What analysts say about Context Therapeutics Inc. stock outlookImmediate Entry Point Prediction Strategy - Newser
What are the latest earnings results for Context Therapeutics Inc.Low Risk Growth Plan With Low Risk - jammulinksnews.com
Full technical analysis of Context Therapeutics Inc. stockFree Community Strategy With High Win Rate - Newser
Best data tools to analyze Context Therapeutics Inc. stockSwing Trading Entry Signals Suggest Opportunity Zone - metal.it
How Resilient Is Context Therapeutics Inc. Stock During Economic DownturnsHigh Conviction Stock Long-Term Summary - Newser
Published on: 2025-07-30 01:03:52 - Newser
Published on: 2025-07-30 09:29:19 - beatles.ru
Context Therapeutics Inc. Breakout Confirmed by Volume MetricsTriple Digit Return Stock Predictions Released - metal.it
Why Context Therapeutics Inc. stock attracts strong analyst attentionFree Access to Real-Time Trade Insights - Newser
Context Therapeutics Inc. Rebound Backed by Sentiment ShiftAlpha Focused Technical Trade Signals Gain Attention - metal.it
Context Therapeutics Inc. stock prediction for this weekReliable Setup Screener with Low Risk - Newser
Context Therapeutics Inc. Stock Support and Resistance Levels You Should KnowAI Trend Detection for Entry Timing - Newser
What is the dividend policy of Context Therapeutics Inc. stockUnlock exclusive stock market forecasts - jammulinksnews.com
What is the risk reward ratio of investing in Context Therapeutics Inc. stockCapitalize on market shifts before others do - jammulinksnews.com
What are the technical indicators suggesting about Context Therapeutics Inc.Unlock powerful trading signals and alerts - jammulinksnews.com
How many analysts rate Context Therapeutics Inc. as a “Buy”Breakout stock performance - jammulinksnews.com
Is it the right time to buy Context Therapeutics Inc. stockCapitalize on momentum stocks early - jammulinksnews.com
Is Context Therapeutics Inc. a growth stock or a value stockAchieve breakthrough gains with smart trades - jammulinksnews.com
What institutional investors are buying Context Therapeutics Inc. stockBreakthrough financial growth - jammulinksnews.com
Why is Context Therapeutics Inc. stock attracting strong analyst attentionDiscover stocks with superior performance - jammulinksnews.com
How strong is Context Therapeutics Inc. company’s balance sheetGet exclusive access to expert stock recommendations - jammulinksnews.com
Sectors Driving Future Growth for Context Therapeutics Inc. StockFree Best Stocks to Buy Today - Newser
Context Therapeutics Presents CTIM-76 Phase 1 Trial in Progress at ASCO 2025 - MSN
What drives Context Therapeutics Inc. stock priceGame-changing capital returns - PrintWeekIndia
Context Therapeutics Inc. Stock Analysis and ForecastExceptional trading results - PrintWeekIndia
Is Context Therapeutics Inc. a good long term investmentRapid growth trajectories - PrintWeekIndia
What analysts say about Context Therapeutics Inc. stockBreakthrough profit margins - PrintWeekIndia
Context Therapeutics Inc (CNTX) 財務データ
収益
当期純利益
現金流量
EPS
Context Therapeutics Inc (CNTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):